Reducing the high cost of insulin in the United States will require multiple changes to the current complex drug pricing system, Mayo Clinic hematologist S. Vincent Rajkumar, MD, argues in a new commentary, The High Cost of Insulin in the United States: An Urgent Call to Action. Read more